NCT03546842
- Conditions
- Adenocarcinoma, Adenocarcinoma in Situ, Carcinoma, +38 more
- Locations
-
- National Institute of Hygiene and Epidemiology ( Site 0001) Hanoi, Vietnam
Clinical trial condition
Papillomavirus Infections
Explore clinical trials studying Papillomavirus Infections. Study availability and eligibility vary by location and protocol.
438 public trials
64 recruiting studies
Papillomavirus Infections trial results
NCT00877877
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
- Locations
-
- GSK Investigational Site Bogotá, Colombia
- GSK Investigational Site Deggingen, Baden-Wurttemberg, Germany
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
NCT00586339
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +31 more
- Locations
-
- GSK Investigational Site Khayelitsha, South Africa
NCT00637195
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +30 more
- Locations
-
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site La Louvière, Belgium
NCT00294047
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
- Locations
-
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Golden, Colorado, United States
- GSK Investigational Site Coral Gables, Florida, United States
NCT00423046
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +23 more
- Locations
-
- GSK Investigational Site Chandler, Arizona, United States
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Vista, California, United States
NCT00359619
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
- Locations
-
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Golden, Colorado, United States
- GSK Investigational Site Salt Lake City, Utah, United States
- GSK Investigational Site Salt Lake City, Utah, United States
NCT00250276
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +12 more
- Locations
-
- GSK Investigational Site Hvidovre, Denmark
- GSK Investigational Site Kaunas, Lithuania
- GSK Investigational Site Klaipėda, Lithuania
- GSK Investigational Site Vilnius, Lithuania
NCT00231413
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- GSK Investigational Site Aurora, Colorado, United States
- GSK Investigational Site Golden, Colorado, United States
- GSK Investigational Site Kingston, Rhode Island, United States
- GSK Investigational Site Salt Lake City, Utah, United States
NCT00196937
- Conditions
- Communicable Diseases, DNA Virus Infections, Disease Attributes, +11 more
- Locations
-
- GSK Investigational Site Munich, Bavaria, Germany
- GSK Investigational Site Würzburg, Bavaria, Germany
- GSK Investigational Site Berlin, Germany
- GSK Investigational Site Bydgoszcz, Poland